Tuberculosis vaccine trials Reply

被引:0
|
作者
Tameris, Michele [1 ]
Hatherill, Mark [1 ]
Mahomed, Hassan [1 ]
McShane, Helen [1 ]
机构
[1] Univ Cape Town, Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, ZA-6850 Worcester, Western Cape, South Africa
来源
LANCET | 2013年 / 381卷 / 9885期
基金
英国惠康基金;
关键词
BCG;
D O I
10.1016/S0140-6736(13)61483-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2254 / 2254
页数:1
相关论文
共 50 条
  • [31] Vaccine trials
    Farrington, CP
    Miller, E
    MOLECULAR BIOTECHNOLOGY, 2001, 17 (01) : 43 - 58
  • [32] MTBVAC: A Tuberculosis Vaccine Candidate Advancing Towards Clinical Efficacy Trials in TB Prevention
    Lacamara, Sergio
    Martin, Carlos
    ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (12): : 821 - 828
  • [33] Vaccine trials
    C. P. Farrington
    E. Miller
    Molecular Biotechnology, 2001, 17 : 43 - 58
  • [34] Evaluation of vaccines to prevent childhood pneumonia: Lessons relevant to planning tuberculosis vaccine trials
    Mulholland, K
    CLINICAL INFECTIOUS DISEASES, 2000, 30 : S206 - S209
  • [35] A Trial of M72/AS01E Vaccine to Prevent Tuberculosis Reply
    不详
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1577 - 1577
  • [36] TUBERCULOSIS - REPLY
    DOWLING, PT
    AMERICAN FAMILY PHYSICIAN, 1991, 44 (04) : 1146 - 1146
  • [37] TUBERCULOSIS - REPLY
    ENARSON, DA
    MAYO CLINIC PROCEEDINGS, 1994, 69 (03) : 297 - 298
  • [38] Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design
    Ibango, Hannah B.
    Brookes, Roger H.
    Hill, Philip C.
    Owiafe, Patrick K.
    Fletcher, Helen A.
    Lienhardt, Christian
    Hill, Adrian V. S.
    Adegbola, Richard A.
    McShane, Helen
    LANCET INFECTIOUS DISEASES, 2006, 6 (08): : 522 - 528
  • [39] Considering human challenge trials for tuberculosis vaccine development (vol 40, pg 173, 2022)
    Kleinwaks, Gavriel
    Schmit, Virginia
    Morrison, Josh
    VACCINE, 2022, 40 (29) : 3984 - 3984
  • [40] Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?
    Nelson, Kristin N.
    Churchyard, Gavin
    Cobelens, Frank
    Hanekom, Willem A.
    Hill, Philip C.
    Lopman, Benjamin
    Mave, Vidya
    Rangaka, Molebogeng X.
    Vekemans, Johan
    White, Richard G.
    Wong, Emily B.
    Martinez, Leonardo
    Garcia-Basteiro, Alberto L.
    LANCET MICROBE, 2023, 4 (08): : E651 - E656